← All themes Genomics & Gene Editing

Gene Therapy

Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.

131 stocks

#	Name	Funds holding	Growth	Growth %	Fund value
51	51 Voyager Therapeutics VYGR $127M	69	-9	-12%	$58.6M
52	52 DELISTED Poseida Therapeutics, Inc. Common Stock PSTX	65	-6	-8%	$191M
53	AGTC 53 DELISTED Applied Genetic Technologies Corporation AGTC	64	-7	-10%	$38.9M
54	54 Instil Bio TIL $41.6M	64	+2	+3%	$1.28B
55	55 4D Molecular Therapeutics FDMT $711M	63	+7	+13%	$515M
56	56 Marker Therapeutics MRKR $15.3M	63	-11	-15%	$44.7M
57	57 Lyell Immunopharma LYEL $201M	62	+10	+19%	$1.22B
58	58 Cabaletta Bio CABA $263M	61	-2	-3%	$211M
59	59 Autolus Therapeutics AUTL $458M	59	-10	-14%	$164M
60	60 Abeona Therapeutics ABEO $266M	58	-12	-17%	$28.3M
61	61 Adicet Bio ACET $48.1M	58	-7	-11%	$156M
62	LOGC 62 DELISTED LogicBio Therapeutics, Inc. Common Stock LOGC	57	-6	-10%	$73.2M
63	SIOX 63 DELISTED Sio Gene Therapies Inc. Common Stock SIOX	56	+2	+4%	$39.9M
64	64 Pluri PLUR $11.9M	55	-4	-7%	$11.8M
65	65 DELISTED BRAINSTORM CELL THERAPUTC BCLI	52	-5	-9%	$16.9M
66	66 Immatics IMTX $1.09B	51	+1	+2%	$292M
67	67 Century Therapeutics IPSC $272M	49	+13	+36%	$496M
68	68 Taysha Gene Therapies TSHA $1.22B	48	-1	-2%	$362M
69	PTE 69 DELISTED PolarityTE, Inc. Common Stock PTE	47	-1	-2%	$6.92M
70	70 Tenaya Therapeutics TNYA $91.6M	47	+47	–	$693M
71	SGTX 71 DELISTED Sigilon Therapeutics, Inc. Common Stock SGTX	45	-7	-13%	$109M
72	72 Eterna Therapeutics ERNA $2.53M	44	+12	+38%	$47.3M
73	SQZ 73 DELISTED SQZ Biotechnologies Company SQZ	44	-5	-10%	$199M
74	74 INmune Bio INMB $45.8M	41	0	0%	$37.7M
75	75 Mesoblast MESO $1.81B	41	-9	-18%	$21.2M